Clinical Trial Update: Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing oral risperidone to injectable paliperidone palmitate for first-episode schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone palmitate (Paliperidone palmitate)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Schizophrenia (Recent-onset) | Phase 4 | Status: COMPLETED